P&G's Post-Earnings Consensus Keeps Building

Why this matters: Procter & Gamble delivered a 4% sales beat on October 22. Five days later, analysts are still raising targets and the remaining short position is evaporating. The data is pointing in one direction.

Analysts Keep Lifting the Bar

Ten analysts revised price targets in the two days following earnings. JP Morgan moved to $180 from $162. UBS raised to $190 from $172. Citigroup lifted to $187 from $180. BNP Paribas went to $189 from $177. The mean consensus target now stands at $173.30.

Freedom Broker added the only outright rating change, upgrading to Buy from Hold with a $176 target. Barclays and Piper Sandler raised targets on October 26 as well, to $165 and $167 respectively, though both kept neutral ratings. The stock closed Monday at $159.92. That puts the mean target roughly 8% above the current price.

Among its closest peers, CL slipped 1.0% over the past week and KMB gained 4.0%. P&G's 1.4% weekly move sits near the peer median of 1.3%. It is neither the most crowded nor the most avoided name in the household products group right now.

Shorts Quietly Exit

Short interest fell 11.9% on October 26 alone. It now sits at 0.92% of the free float, the lowest reading in four weeks. The one-month decline is 24%. This continues the post-earnings covering trend documented after the October 22 print.

The borrow market confirms the direction of travel. Cost to borrow dropped to 0.08% on October 26, down 76% over the week. Availability stands at 9,999% of current short interest. There is no friction in this lending market. Anyone who wanted to exit a short position has had every reason and every opportunity to do so.

Corroborating Context

The CEO, Shailesh Jejurikar, sold 35,000 shares on October 23 at $163.09, a transaction worth $5.7 million. The sale was not filed under a 10b5-1 plan. The 90-day net insider position is a net sale of roughly $12.9 million. These are not signals of distress, they are typical post-earnings liquidity events at a company where the stock has risen 9.4% over the past month.

Capital Research and Management added 6.4 million shares as of September 30, the largest single institutional position change among the top holders. Charles Schwab Investment Management added 3.5 million shares in the same period.

The ORTEX alt data layer flags that P&G's buyback spend in the April quarter was $875 million, up 25% on the same quarter a year earlier.

---

What to watch: The mean analyst target of $173.30 is the reference level now. The stock needs to close and hold above roughly $167, where the most cautious post-earnings target revisions cluster, for the constructive consensus to carry further weight.